NCT03533257 - Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 14, 2018

Primary Completion Date

October 22, 2020

Study Completion Date

November 6, 2020

Conditions

Alzheimer Disease

Interventions

DRUG

AMX0035

Combination Therapy of PB and TURSO

DRUG

Placebo

Trial Locations (11)

Mount Sinai Alzheimer's Disease Research Center, New York

Columbia University, New York

Hospital of the University of Pennsylvania, Penn Memory Center, Philadelphia

Clinical Neuroscience Solutions, Inc. - Jacksonville, Jacksonville

Clinical Neuroscience Solutions, Inc. - Orlando, Orlando

International Medical Investigational Centers (IMIC), Palmetto Bay

Genesis NeuroScience Clinic, Knoxville

Rush University Medical Center, Chicago

University of Kansas Clinical Research Center, Fairway

Massachusetts General Hospital, Boston

Rowan University School of Osteopathic Medicine, Stratford